In our study half of the patients with pathogenic mutations had high or moderate penetrance genes not traditionally associated with CRC (2, BRCA1; 3, BRCA2; 1, ATM/NBN; 3, FANCI; 1, DICER1; and 1, AIP). The gene discussed is BRCA2; the disease is colorectal carcinoma.